Bills · H.R. 11039 · Text
Introduced in House
Confirmed from the official record
Our copy of the file on govinfo.gov, saved November 19, 2026. Fingerprint (SHA-256): 3c428c7b86f617ef.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 11039 Introduced in House (IH)]
<DOC>
119th CONGRESS
2d Session
H. R. 11039
To expand Federal investment in pediatric cancer research, improve
access to clinical trials, support holistic and innovative therapies,
reduce the financial burden on families, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
November 17, 2026
Mr. Boyle of Pennsylvania introduced the following bill; which was
referred to the Committee on Energy and Commerce, and in addition to
the Committees on the Budget, and Ways and Means, for a period to be
subsequently determined by the Speaker, in each case for consideration
of such provisions as fall within the jurisdiction of the committee
concerned
_______________________________________________________________________
A BILL
To expand Federal investment in pediatric cancer research, improve
access to clinical trials, support holistic and innovative therapies,
reduce the financial burden on families, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Ahmad Butler Pediatric Cancer Hope
for a Cure Act''.
SEC. 2. FINDINGS.
Congress finds the following:
(1) Pediatric cancer is the leading cause of disease-
related death in children in the United States.
(2) Many children face outdated treatments, long waiting
periods, and limited clinical trial access.
(3) Families often face extraordinary financial hardship
related to clinical trial participation.
(4) Improved investment, coordinated Federal action, and
expanded access are necessary to protect and save children
battling life-threatening cancers.
(5) Children from minority, rural, and low-income
communities face disproportionate barriers to accessing
pediatric cancer care and clinical trials.
SEC. 3. PURPOSES.
The purposes of this Act are the following:
(1) To expand federally protected and sustained funding for
pediatric cancer research.
(2) To accelerate scientific discovery with emphasis on the
deadliest childhood cancers.
(3) To ensure nationwide access to pediatric clinical
trials regardless of a family's income or location.
(4) To study and evaluate holistic, integrative, and non-
traditional therapies.
(5) To provide families with financial support to
participate in clinical trials.
(6) To establish annual public reporting and accountability
of Federal pediatric cancer investments.
SEC. 4. RESEARCH AND PRIORITY AREAS.
The Secretary of Health and Human Services shall expand and
intensify efforts to conduct pediatric cancer research, including in
the following priority areas:
(1) High-risk and rare pediatric tumors.
(2) Childhood brain cancers.
(3) Relapsed and treatment-resistant cancers.
(4) Survivorship, long-term effects, and quality of life.
SEC. 5. HOLISTIC AND INNOVATIVE THERAPY RESEARCH.
(a) Study and Evaluation.--The Secretary of Health and Human
Services, acting through the Director of the National Institutes of
Health, shall establish a research initiative to study holistic,
integrative, nutritional, and alternative therapies for pediatric
cancer that emphasizes rigorous, evidence-based scientific evaluation
consistent with the research mission of the National Institutes of
Health.
(b) Requirements.--Such research shall--
(1) be evidence-based;
(2) prioritize safety and efficacy;
(3) include culturally competent and family-centered
approaches; and
(4) not stop at curing cancer, but also study how to
protect survivors from long-term complications and improve
their everyday lives after treatment.
SEC. 6. PEDIATRIC CLINICAL TRIAL ACCESS ASSISTANCE GRANTS.
(a) Establishment.--The Secretary of Health and Human Services (in
this section referred to as the ``Secretary'') shall award grants to--
(1) individuals participating in pediatric cancer clinical
trials (including the caretakers and family members of such
individuals); and
(2) entities conducting or supporting pediatric cancer
clinical trials.
(b) Applications.--To be eligible to receive a grant under this
section, an individual or entity described in subsection (a) shall
submit to the Secretary an application at such time, in such manner,
and containing such information as the Secretary determines
appropriate.
(c) Use of Funds.--
(1) Individuals.--An individual who receives a grant under
this section may use the grant to cover travel, lodging, meals,
transportation, childcare, unpaid leave expenses, or other
trial-related costs, as the Secretary determines appropriate,
for participating in pediatric cancer clinical trials.
(2) Entities.--An entity that receives a grant under this
section may use the grant to expand sites for pediatric cancer
clinical trials in medically underserved regions, as the
Secretary determines appropriate.
SEC. 7. ANNUAL REPORTS TO CONGRESS.
(a) Requirement.--The Secretary of Health and Human Services shall
submit to Congress a report on an annual basis regarding pediatric
cancer research, including the research conducted pursuant to this Act.
(b) Contents.--The reports described in subsection (a) shall
include the following:
(1) Total funds allocated and expended for pediatric cancer
research, including contributions made to the One Lunch 4 Cure
National Pediatric Cancer Contribution Fund under section 8.
(2) Research accomplishments related to pediatric cancer
research.
(3) Progress on high-risk pediatric cancer cures.
(4) Clinical trial enrollment data and equity gaps with
respect to pediatric cancer research.
(5) Descriptions of the pediatric clinical trial access
assistance grants awarded under section 6.
(6) Recommendations for legislative or administrative
action with respect to pediatric cancer research.
SEC. 8. ONE LUNCH 4 CURE NATIONAL PEDIATRIC CANCER CONTRIBUTION FUND.
(a) Establishment.--The Secretary of the Treasury shall establish a
fund, to be known as the One Lunch 4 Cure National Pediatric Cancer
Contribution Fund (in this section referred to as the ``Fund''). Each
contribution made under this section shall be appropriated to the Fund
on the date such contribution is made and shall remain available until
expended.
(b) Methods of Contributions.--Contributions to the Fund may be
made through--
(1) one-time voluntary donations representing the cost of
one lunch;
(2) recurring voluntary donations representing the cost of
one lunch per week or one lunch per month;
(3) voluntary payroll deductions for Federal civilian
employees and members of the Armed Forces;
(4) designations on individual Federal income tax returns
as provided in subsection (f);
(5) employer-matching programs; and
(6) any other method determined appropriate by the
Secretary of the Treasury.
(c) Sources of Contributions.--Any individual or entity may make a
contribution to the Fund, including--
(1) a pediatric cancer nonprofit organization;
(2) a charitable foundation;
(3) a children's hospital;
(4) a research institution; and
(5) a philanthropic partner organization.
(d) Use of Funds.--The Secretary of Health and Human Services shall
use amounts in the Fund for the following purposes:
(1) The pediatric cancer research described in sections 4
and 5.
(2) The pediatric clinical trial access assistance grants
described in section 6.
(3) Equity initiatives to expand access for underserved
communities with respect to pediatric cancer research and
treatment.
(4) Support for military families affected by pediatric
cancer.
(e) Oversight and Transparency.--
(1) Annual gao audit.--The Comptroller General of the
United States shall--
(A) conduct an annual audit of contributions
received and distributed under this section; and
(B) submit to Congress a report describing the
results of each such audit.
(2) Prohibition on use for administrative expenses.--
Amounts in the Fund may not be used for the administrative
expenses of any Federal agency, including the Department of the
Treasury, the National Institutes of Health, and the National
Cancer Institute.
(f) Contributions Made in Connection With Individual Federal Income
Tax Returns.--The Secretary of the Treasury shall ensure that each
individual Federal income tax return form includes a line that allows
the taxpayer to designate any overpayment (including any overpayment
attributable to any payment made with such return) as a contribution to
the One Lunch 4 Cure National Pediatric Cancer Contribution Fund and
shall ensure that any amount so designated is transferred to such Fund.
(g) Budgetary Effects.--
(1) Statutory paygo scorecards.--The budgetary effects of
this section shall not be entered on either PAYGO scorecard
maintained pursuant to section 4(d) of the Statutory Pay-As-
You-Go Act of 2010 (Public Law 111-139; 2 U.S.C. 933(d)).
(2) Senate paygo scorecards.--The budgetary effects of this
section shall not be entered on any PAYGO scorecard maintained
for purposes of section 4106 of H. Con. Res. 71 (115th
Congress).
SEC. 9. RULE OF CONSTRUCTION.
Nothing in this Act shall reduce or replace existing pediatric
cancer programs.
SEC. 10. FUNDING.
(a) Appropriation.--There is appropriated to carry out this Act,
not including section 8, $2,000,000,000 for the period of fiscal years
2027 through 2036.
(b) Protected Allocation.--The amount appropriated by subsection
(a) shall not be reallocated from pediatric research to adult cancer
programs.
<all>